10.03.2015 • News

DKSH and DFE Pharma Sign Distribution Agreement for Eight European Countries

DKSH's Business Unit Performance Materials has been appointed exclusive Market Expansion Services partner for DFE Pharma's Pharmacel MCC excipient for France, Switzerland, UK, Ireland, Denmark, Finland, Norway and Sweden.

DKSH presently partners DFE Pharma in the Philippines, where DKSH provides Market Expansion Services to DFE Pharma's starch and disintegrants product range.

"We are very pleased that DFE Pharma has chosen DKSH once again as their Market Expansion Services partner for the distribution of their Pharmacel MCC excipient. Thanks to our unmatched footprint in Europe, we can leverage on our size, experience and industry know-how to provide tailored services and exceptional distribution opportunities for DFE Pharma," said Tanja Schaffer, Vice President Pharmaceutical Industry, DKSH Performance Materials.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read